BABAK HOSSEINI, O.D.
Optometrist in BETHESDA, Maryland. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
BABAK HOSSEINI, O.D. reported a CMS MIPS final score of 86.9705/100 — above the 83.1 national average — and filed 178 Medicare Part D claims in 2023.
- 86.9705/100
- MIPS score · +4 vs avg
- 178
- Part D claims, 2023
- 50%
- generic prescribing
- $446.96
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
BABAK HOSSEINI, O.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
87 Top 48% higher than 52% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
What does the federal data show about BABAK HOSSEINI, O.D.?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Maryland
How Optometrist compares to other specialties among Maryland providers
Optometrist share within Maryland
Optometrist is one of the more visible NUCC categories in Maryland
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
BABAK HOSSEINI, O.D.'s 2023 MIPS final score plotted against the Optometrist national average
- MIPS Final Score
- 86.9705/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Optometrist) — 86.9705/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Optometrist US NPIs
86.9705/100 MIPS final score — 3.9 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Optometrist. Quality dim: 100. Cost dim: 48.4065.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
BABAK HOSSEINI, O.D. appears in the CMS NPPES registry as a Optometrist provider holding O.D. credentials at 7101 DEMOCRACY BLVD, BETHESDA, MD, 20817, with a listed phone of (301) 365-3670. NPI 1225390446 was issued on 06/13/2012. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what HOSSEINI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 178 prescription claims written by this provider, covering 76 Medicare beneficiaries and totaling roughly $102K in drug spend, split 50% brand-name and 50% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 86.9705/100 for the 2023 performance year (Quality 100, Cost 48.4065), compared with the national average of 83.1.
Optometrist is a high-volume specialty nationwide, with 60,463 enrolled providers across 56 states and an average of 257 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1225390446 |
|---|---|
| Specialty | Optometrist |
| Credentials | O.D. |
| Gender | Male |
| NPI Issued | 06/13/2012 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm BABAK HOSSEINI, O.D.'s current license status, disciplinary history, and board certifications with the Maryland Board of Physicians in Maryland before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where BABAK HOSSEINI, O.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for BABAK HOSSEINI, O.D.. Source: openpaymentsdata.cms.gov.
Total received
$447
Largest payer
Mallinckrodt Hospital Products Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Brand-heavy
50% brand-name claims vs 50% generic, on 178 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 305
- Total Day Supply
- 8,077
- Brand vs Generic
- 50% brand / 50% generic
- Brand Drug Cost
- $93K
- Generic Drug Cost
- $8K
Patient Demographics
- Average Patient Age
- 75.1 years
- Avg HCC Risk Score
- 1.02
- Gender Split
- 72% female / 28% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What BABAK HOSSEINI, O.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Restasis
Restasis
39 claims
- Neomycin-Polymyxin…
Neomycin-Polymyxin-Dexameth
20 claims
- Erythromycin 13
Erythromycin
13 claims
- Latanoprost 12
Latanoprost
12 claims
- Moxifloxacin 12
Moxifloxacin
12 claims
- Cyclosporine 11
Cyclosporine
11 claims
| Drug | Claims |
|---|---|
| Restasis Cyclosporine | 39 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 20 |
| Erythromycin Erythromycin Base | 13 |
| Latanoprost | 12 |
| Moxifloxacin Moxifloxacin Hcl | 12 |
| Cyclosporine | 11 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Optometrist Overview
How BABAK HOSSEINI, O.D. fits within the Optometrist landscape nationally.
BABAK HOSSEINI, O.D.'s 178 claims are below the specialty average of 257.
Nearby Optometrist Providers in Maryland
Other clinicians with the same primary specialty enrolled in Maryland, drawn from the same CMS NPPES roster as HOSSEINI.
Compare Optometrist nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Maryland
Frequently Asked Questions
What is BABAK HOSSEINI, O.D.'s specialty? ▼
How much does BABAK HOSSEINI, O.D. prescribe under Medicare Part D? ▼
What is BABAK HOSSEINI, O.D.'s Medicare quality score? ▼
Where is BABAK HOSSEINI, O.D. located? ▼
What is BABAK HOSSEINI, O.D.'s NPI number? ▼
Does BABAK HOSSEINI, O.D. prescribe more brand-name or generic drugs? ▼
How many Optometrist providers are there in the US? ▼
What drugs does BABAK HOSSEINI, O.D. prescribe most often? ▼
Does BABAK HOSSEINI, O.D. accept Medicare? ▼
How can I verify BABAK HOSSEINI, O.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology